Interleukin Genetics, Inc. and the University of North Carolina at Chapel Hill Announce Key Genetic Findings from Clinical Study on Osteoarthritis that are Predictive of Disease Progression - Drugs.com MedNews
Links shared publicly online about this topic.
- 854total visits
Interleukin Genetics, Inc. and the University of North Carolina at Chapel Hill Announce Key Genetic Findings from Clinical Study on Osteoarthritis that are Predictive of Disease Progression - Drugs.com MedNews
Findings Could Serve in Drug Development Trials and Medical Management of Osteoarthritis Patients Interleukin Genetics, Inc. (OTC QB ILIU) and the Thurston Arth
View full resource at drugs.com
Tags: Genetic, Osteoarthritis, Disease and Condition, Drug, disease, Medical, Genetics
Most Recently Shared on September 22, 2010 at 6:12 pm By:
Interleukin Genetics, Inc. and the University of North Carolina at Chapel Hill Announce Key Genetic Findings ... http://bit.ly/aELpOR #drug
Advertisement
